PhysIOL Announces Full Ownership of Optikon
After the acquisition of a majority stake in the Italian company Optikon on September 17, 2017, PhysIOL announced that it has completed the acquisition of the minority shares, leading to an 100% ownership of Optikon.
Terms of the deal were not disclosed.
Italy-based Optikon develops and markets ophthalmic devices, including phaco, vitrectomy, and diagnostic equipment. Optikon’s product portfolio includes the R-Evolution and Pulsar machines.
You must be logged in to leave a comment.